Research Highlight Published: June 2010 Cerebral embolisms after TAVI Bryony M. Mearns Nature Reviews Cardiology 7, 301 (2010) Cite this article ...

Research Highlight Published: 25 February 2011 Interventional cardiology TAVI—transcatheter approach choice does not affect cerebral embolisms Bryony M. Mearns Nature Reviews Cardiology 8, 120 ...

It’s unknown what, if any, pulmonary or cardiac damage Bosh may have suffered as a result of his embolisms. But, even if there was no damage at all, Gottsegen says he wouldn’t be cleared to ...

Rates of cerebral embolisms associated with TAVI procedures reached 70% for both types of procedure but apparently had no neurological or cognitive correlates.

Pulmonary embolisms are the third most common cause of death in hospitalized patients. They mostly affect older people, but, obviously, the young, fit and healthy can get them, too.

Pulmonary embolisms are dangerous, lung-clogging blot clots. In a pilot study, scientists showed that artificial intelligence (AI) algorithms can detect signs of these clots in electrocardiograms ...

Pulmonary embolisms aren't always fatal: In some cases, smaller clots restrict blood flow and airflow into the lungs without creating a full blockage. That can decrease blood-oxygen levels — a ...

According to the U.S. Centers for Disease Control, up to 100,000 Americans die annually from pulmonary embolisms caused by DVT — and around 25% never have a symptom before dying suddenly.

The lipid kinase PI3KC2a is a potential pharmacological target for the treatment of thrombosis and, possibly, cancer. Researchers from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie ...

Doctors at NYC Health + Hospitals/Jacobi are now treating pulmonary embolisms in an innovative way with a new tool they say will save lives.

Pulmonary embolisms kill about 25,000 Americans annually, according to the Centers for Disease Control and Prevention; one apparently killed NBC war correspondent David Bloom on Sunday.

Crux Biomedical has raised $8 million in second-round funding to cover its debt and finalize clinical trials on its device used to remove blood clots and air bubbles from the bloodstream. The ...